Lawyers nationwide are gearing up for bellwether ovarian cancer trials against Johnson & Johnson this year, but a plaintiff ...

National pre-settlement funding provider continues strategic focus on late-stage, mid-stage, and emerging pharmaceutical and medical device litigation JERSEY CITY, N.J., March 5, 2026 /PRNewswire/ -- ...

If you used talc as a child, or still use it now, here’s what the science says about the link with cancer. It might not be ...

Johnson and Johnson announced on Tuesday that it will stop distributing talc-based baby powder “to prioritize high-demand products and to allow for appropriate social distancing in manufacturing and ...

Philadelphia jury orders Johnson & Johnson to pay damages in a talc related ovarian cancer case, the first plaintiff win ...

TORONTO, March 6, 2026 /CNW/ - A Canada-wide talc class action was certified against Johnson & Johnson on March 4, 2026, by Justice Leiper of the Ontario Superior Court of Justice. This class action ...

Dean Omar Branham & Shirley, the Dallas plaintiffs' firm that won verdicts of $966 million and $1.5 billion last year, is spearheading both mesothelioma trials that are set to begin in the coming days ...

Johnson & Johnson (NYSE:JNJ) was found liable by a Philadelphia jury in an ovarian cancer case linked to long term use of its talc based baby powder. The jury awarded compensatory and punitive damages ...

A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson (JNJ) caused their ovarian cancer. The giant health care company said it would ...